Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events
International Journal of Clinical Practice · 2024
DOI: 10.1155/2024/6219301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Clinical Practice, 2024. Verfasst von Ali Z Zgheib und 7 weiteren Autor:innen. Beteiligte Einrichtung: American University of Beirut Medical Center, Division of Cardiology, Beirut, Lebanon. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Rates of major bleeding and intraprocedural thrombotic events (IPTE) in the setting of percutaneous coronary intervention (PCI) using weight-adjusted unfractionated heparin (UFH) without activated clotting time (ACT) monitoring are not known.
Methods
We reviewed 2,748 consecutive patients who underwent coronary angiography at our tertiary care university hospital between January 2017 and December 2020. All patients who underwent PCI with weight-adjusted UFH without ACT guidance were considered for further analysis. Major bleeding complications occurring within 48 hours of PCI were collected from patients’ medical records. IPTE were collected independently by two interventional cardiologists after review of coronary angiograms.
Results
There were 718 patients included in the analysis (65.4 ± 12.2 years old; 81.3% male). In total, 45 patients (7.8%) experienced a major bleed or IPTE. The most common IPTE were slow/no reflow (1.5%) and coronary artery dissection with decreased flow (1.1%). Other IPTE occurred in
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- American University of Beirut Medical Center, Division of Cardiology, Beirut, Lebanon.
- McGill University Health Centre, Division of Cardiology, Montreal, Canada.
- University of California at Los Angeles, Division of Cardiology, Los Angeles, California, USA.
ORCID-Profile: Ali Z Zgheib, Abdallah G Rebeiz
Zitieren
APA
Zgheib, A. Z., Jdaidani, J., Akl, E., Khalil, S., Chaabo, O., Piazza, N., Sawaya, F. J., & Rebeiz, A. G. (2024). Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events. International Journal of Clinical Practice. https://doi.org/10.1155/2024/6219301
Vancouver
Zgheib AZ, Jdaidani J, Akl E, Khalil S, Chaabo O, Piazza N, et al. Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events. International Journal of Clinical Practice. 2024. doi:10.1155/2024/6219301
BibTeX
@article{Zgheib2024,
author = {Zgheib, Ali Z and Jdaidani, Jennifer and Akl, Elie and Khalil, Suzan and Chaabo, Omar and Piazza, Nicolo and Sawaya, Fadi J and Rebeiz, Abdallah G},
title = {Percutaneous Coronary Intervention with Procedural Unfractionated Heparin without Activated Clotting Time Guidance: A Unique Opportunity to Assess Thrombotic and Bleeding Events},
journal = {International Journal of Clinical Practice},
year = {2024},
doi = {10.1155/2024/6219301}
}
EUVIMED